Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study-Reference-Cited by-同舟云学术

Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study

Published:2019-06 Issue: Volume:212 Page:64-71
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Strom Jordan B.,Tamez Hector,Zhao Yuansong,Valsdottir Linda R.,Curtis Jeptha,Brennan J. Matthew,Shen Changyu,Popma Jeffrey J.,Mauri Laura,Yeh Robert W.

Funder

National, Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stenting;Yeh;Circulation,2011

2. The randomized registry trial—the next disruptive technology in clinical research?;Lauer;N Engl J Med,2013

3. Thrombus aspiration during ST-segment elevation myocardial infarction;Frobert;N Engl J Med,2013

4. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial;Rao;JACC Cardiovasc Interv,2014

5. Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction : a secondary analysis of the TRANSLATE-ACS Study;Guimaraes;JAMA Cardiol,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physician and patient adherence in hypertension trials: a point of view on an important issue to resolve;Expert Review of Pharmacoeconomics & Outcomes Research;2024-06-05

2. Days at Home After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients;Circulation: Cardiovascular Quality and Outcomes;2023-12

3. Association Between Claims‐Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND‐DAPT Study;Journal of the American Heart Association;2023-07-18

4. Residential Racial Segregation in Aortic Stenosis Diagnosis and Transcatheter Aortic Valve Implantation Among Medicare Patients;JACC: Advances;2023-07

5. Days at home after transcatheter or surgical aortic valve replacement in high-risk patients;American Heart Journal;2023-01